FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30475207.
- Also identified by DOI 10.7554/eLife.38579 and PMC identifier 6303105.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Changes in cancer cell identity can alter malignant potential and therapeutic response. Loss of the pulmonary lineage specifier NKX2-1 augments the growth of KRAS-driven lung adenocarcinoma and causes pulmonary to gastric transdifferentiation. Here, we show that the transcription factors FoxA1 and FoxA2 are required for initiation of mucinous NKX2-1-negative lung adenocarcinomas in the mouse and for activation of their gastric differentiation program. <i>Foxa1/2</i> deletion severely impairs tumor initiation and causes a proximal shift in cellular identity, yielding tumors expressing markers of the squamocolumnar junction of the gastrointestinal tract. In contrast, we observe downregulation of FoxA1/2 expression in the squamous component of both murine and human lung adenosquamous carcinoma. Using sequential in vivo recombination, we find that FoxA1/2 loss in established KRAS-driven neoplasia originating from SPC-positive alveolar cells induces keratinizing squamous cell carcinomas. Thus, NKX2-1, FoxA1 and FoxA2 coordinately regulate the growth and identity of lung cancer in a context-specific manner.
Medical subject headings
- Adenocarcinoma of Lung
- Biomarkers, Tumor
- Carcinoma, Squamous Cell
- Gene Expression Regulation, Neoplastic
- Hepatocyte Nuclear Factor 3-alpha
- Hepatocyte Nuclear Factor 3-beta
- Lung Neoplasms
- Stomach Neoplasms
- Thyroid Nuclear Factor 1